EXECUTIVE CLINICAL BRIEFING FOR PATIENTS & CLINICIANS
Why Your Body Fights Dieting: The Incretin Reset & $69/mo Flat GLP-1 Access
See how natural incretin hormones (GLP-1 and GIP) silence persistent food noise in the brain, why commercial dose escalation prices force patients to quit, and how to access doctor-prescribed flat-rate $69/mo Semaglutide and $119/mo Tirzepatide with zero hidden fees.
Why You Should Watch This Clinical Briefing
Over 95% of conventional calorie-deficit diets fail within 24 months due to metabolic adaptation—an ancient evolutionary defense mechanism where your body slows resting metabolism and elevates ghrelin (the hunger hormone) in response to caloric restriction.
This 7-minute clinical briefing by our medical directorate reveals how modern incretin receptor signaling restores natural hypothalamic satiety, silences persistent food noise, and enables doctor-supervised weight loss at transparent flat-rate pricing.
Here is what you will learn inside this free session:
The Biological Hunger Trap & Metabolic Adaptation
Why cutting calories inevitably increases ghrelin (the hunger hormone) and lowers basal metabolic rate, making long-term weight maintenance biologically impossible through willpower alone.
The Incretin Receptor Mechanism (GLP-1 & GIP)
How GLP-1 and dual GIP/GLP-1 receptor agonists bind to hypothalamic appetite centers, slow gastric motility, silence constant food noise, and trigger deep physiological satiety.
The Commercial Dose-Escalation Trap Exposed
How commercial telehealth platforms lure patients in with a cheap $199 introductory teaser, then hike prices to $399–$699/month once dosages ramp up. See the real pharmacy cost curve.
State-Licensed 503A Compounding Pharmacy Purity
How Telehealth FX partners directly with licensed 503A compounding pharmacies to deliver flat-rate Semaglutide at $69/mo and Tirzepatide at $119/mo across all dosages with zero hidden fees.
Confidential 60-Second Medical Pre-Qualification Check
Find out how to complete our 60-second doctor screening form to verify your clinical qualification and route directly to a licensed physician in your state.
Compounded Semaglutide and Tirzepatide contain the identical active pharmaceutical ingredients (APIs) as the commercial brand-name medications. They are prepared by state-licensed 503A compounding pharmacies using USP-grade active peptides with independent batch potency, sterility, and endotoxin testing. While commercial brands retail for –,350/mo, compounded access starts at just /mo flat.
Commercial telehealth platforms typically advertise a teaser rate and then quietly double or triple your billing (–/mo) once your doctor titrates you to therapeutic dosages. Telehealth FX operates on a true flat-rate clinical model: /month flat for Semaglutide and /month flat for Tirzepatide regardless of whether your dose is 0.25mg or maximum 2.5mg / 15mg.
The intake is 100% digital and takes under 3 minutes. You complete a confidential medical profile detailing your health history and weight management goals. A board-certified U.S. physician licensed in your state reviews your chart within 24 hours. If clinically appropriate, they issue your electronic prescription directly to our partner 503A compounding pharmacy.
Medications are compounded under sterile conditions and shipped directly to your door in express temperature-controlled packaging with medical-grade cold packs. Syringes, alcohol swabs, and precise titration dosing instructions are included with every delivery.
Patient safety is our primary clinical obligation. If our licensed physician determines that GLP-1 or GIP therapy is contraindicated for you (e.g. personal or family history of medullary thyroid carcinoma or MEN 2), you are not billed a single dollar for medication and you receive clinical guidance on alternative approaches.